Gastroenterology

A large proportion of HCV patients remain undiagnosed, particularly in the older population.

Vonoprazan has shown more potent acid inhibitory effects than PPI.

An electronic reminding system helped identify 3783 patients with anti-HCV antibody documentation.

The presence of extra-intestinal manifestations in biologic-naïve anti-TNF patients with Crohn’s disease was a predictor of disease severity.

The majority of adverse effects reported were considered mild.

More than 40% of the treatment arm of the placebo-controlled trial achieved a complete renal response.

Histologic scores in the endoscopically involved mucosa of index biopsies not linked to subsequent extension of ulcerative colitis.

The CDC currently recommends every pregnant woman screened for hepatitis C virus.

Females and older patients had higher rates of hospitalizations with CDI than males and younger patients.

Marla Dubinsky, MD, discusses what needs to be done to improve care for children with ulcerative colitis.

Researchers recently completed a 16-week phase 2b trial for patients with ulcerative colitis.

Marla Dubinsky, MD, discusses what adding adalimumab to the pediatric ulcerative colitis toolbox means for treatment strategies.

New data affirms a low rate of hepatitis B vaccination responsiveness among patients with hepatitis B core antibodies.

The study authors said that decentralizing dispensation of hepatitis C treatment re-engages patients.

There is a need for cost-effective treatments for HCV in low-income countries.

The amount of minimally invasive surgeries has increased between 2010-2017.

New data has investigators caution against the discontinuation of ulcerative colitis treatment, due to threat of relapse.

COVID-19 patients receiving at least 2 antibiotics were at a higher CDI risk.

Direct-acting antivirals have been a major milestone in the treatment of hepatitis C virus, new data show they also work in nearly all children, without serious adverse events.

ABX464 is being tested for numerous indications, including ulcerative colitis.

Raising awareness about proper treatment adherence is one method of working toward eliminating hepatitis C.

More than 90% of patients with hepatitis C who sought care at a comprehensive community health clinic completed treatment, and three-quarters of those returned for sustained virologic response testing.

Patients with C. diff infections had nearly a 5 day longer length of hospital stay than a group without CDI.

Dr. Nigel Bunnett talks about future plans to test a new IBD treatment.

Medtronic claims the GI Genius module will help clinicals identify lesions in real time during a colonoscopy.